Hazardous Alcohol Use and Its Effect on Direct-Acting Antiviral Therapy Initiation among People with Active Injection Drug Use and Current Hepatitis C Infection
There was a high prevalence of hazardous alcohol use, low rates of oral DAA therapy initiation, and no association between self-reported hazardous alcohol use and initiation of oral DAA therapy in our sample of PWID that were aware of their chronic HCV infection. Strategies to increase HCV treatment uptake in PWID with active drug use are urgently needed and should integrate alcohol and drug use evaluation and care.
Authors
- Kathleen R. Page (ORCID: https://orcid.org/0000-0002-6859-1973)
- Oluwaseun O Falade-Nwulia (ORCID: https://orcid.org/0000-0003-2321-2295)
- Gregory M. Lucas (ORCID: https://orcid.org/0000-0002-3013-4339)
- Miles Landry (ORCID: https://orcid.org/0000-0002-1207-9954)
- Katie Zook
- Brian W. Weir (ORCID: https://orcid.org/0000-0003-1634-218X)
- Hamidreza Karimi‐Sari (ORCID: https://orcid.org/0000-0002-6827-9496)
- Susan G. Sherman
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
Publication Details
- Journal
- Viruses
- Published
- 2024-09-05
- DOI
- https://doi.org/10.3390/v16091416
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00